GSK Archives

In Depth 3 Jul 2023

Hepatitis B: are we edging closer to a cure?

A viral infection that affects the liver and can cause both acute and chronic disease, hepatitis B affects around 296 million people worldwide, and, according to the latest statistics from…

July 3, 2023 - 6 minutesmins - By Willow Shah-Neville

Neisseria gonorrhoeae gonorrhoea gonorrhea

News and Trends 27 Jun 2023

GSK gonorrhea vaccine fast tracked

The US Food and Drug Administration (FDA) has granted a Fast Track designation for GSK plc's Neisseria gonorrhoeae investigational vaccine (NgG). The vaccine candidate is currently in an ongoing phase…

June 27, 2023 - 3 minutesmins - By Jim Cornall

More News! 6 Jun 2023

$5.5M funding for Oncopole to tackle cancer

Oncopole, Fonds de recherche du Québec - Santé (FRQS) cancer division in Canada, has received major investments that boost its public-private partnership model dedicated to the fight against cancer. Oncopole…

June 6, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 4 May 2023

World’s first RSV vaccine for older adults gets FDA approval

GSK plc says the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory…

May 4, 2023 - 5 minutesmins - By Jim Cornall

Opinion 26 Apr 2023

How to address declining vaccination rates in older adults

By Philip Dormitzer, global head of vaccines research and development, GSK The vaccines landscape has changed greatly over the last few years in light of the COVID-19 pandemic. New technologies…

April 26, 2023 - 5 minutesmins - By External Contributor

BIO-Europe Spring, Element Materials Technology, Ergomed, Rentschler Biosciences

News and Trends 8 Mar 2023

How to promote diversity in STEM

Leaders from OMass Therapeutics, SiSaf and Brainomix explain how to promote diversity in science, technology, engineering and math (STEM). OMass Therapeutics is a female-led business with diversity at its core.…

March 8, 2023 - 6 minutesmins - By Jim Cornall

Expert Advice 2 Mar 2023

5 steps to strategic partnerships for healthtech startups

By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities than outright acquisitions. While the M&A path is set out…

March 2, 2023 - 6 minutesmins - By External Contributor

News and Trends 10 Feb 2023

FDA approves GSK drug for recurrent or advanced mismatch repair-deficient endometrial cancer

GSK plc says the US Food and Drug Administration (FDA) has given full approval for Jemperli (dostarlimab-gxly) for the treatment of adult patients with mismatch repair-deficient (dMMR) recurrent or advanced…

February 10, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 9 Feb 2023

Cell and Gene Therapy Catapult boost for life science campus

The Cell and Gene Therapy Catapult (CGT Catapult), an independent U.K. innovation and technology organization specializing in the advancement of cell and gene therapies, has announced its involvement in the…

February 9, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 10 Nov 2022

Sanofi and GSK Covid-19 booster vaccine approved by European Commission

Sanofi and GSK’s Covid booster vaccine has been approved in Europe. After the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn…

November 10, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 9 Aug 2022

Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment

A global collaboration was announced today (August 9) between Mersana Therapeutics Inc and GSK plc that will give GSK the option to co-develop and commercialize an antibody drug conjugate (ADC).…

August 9, 2022 - 3 minutesmins - By Liza Laws

News and Trends 13 Jun 2022

GSK positive on RSV vaccine for older adults

GSK plc has announced positive headline results from its AReSVi 006 phase III trial. AReSVi 006 is a phase III trial investigating GSK’s respiratory syncytial virus (RSV) vaccine candidate for…

June 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 2 Jun 2022

Upstream Bio to target asthma as it launches with $200M financing

Upstream Bio, a U.S. biotech company focused on inflammation, today exited stealth mode with $200M Series A financing. The company said the funding will allow it to advance its lead…

June 2, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax

GSK plc is set to acquire Affinivax, Inc., a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1B upfront payment and up to $1.2B in potential development milestones. …

June 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 30 Jun 2021

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month, wondering if it overpaid for the Belgian company’s next-generation checkpoint inhibitor. GSK’s oncology deal with…

June 30, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 15 Jan 2021

GSK Acne Deal Heralds Growing Interest in Skin Microbiome

This week, the Paris-based Eligo Bioscience became one of a growing number of biotechs to land a big pharma deal focused on the skin microbiome, receiving up to €185M from…

January 15, 2021 - 4 minutesmins - By Kostas Vavitsas

News and Trends 23 Jul 2020

Pharma Giant GSK and mRNA Biotech CureVac Ink €1B Deal

GlaxoSmithKline (GSK) has struck a deal worth up to €1B with the German biotechnology company CureVac to co-develop messenger RNA drugs for infectious diseases. Under the terms of the deal,…

July 23, 2020 - 3 minutesmins - By David Wilson

News and Trends 23 Mar 2020

ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada

A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for the treatment of HIV in Canada, which could replace the need for daily antiretroviral pills.…

March 23, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 25 Feb 2020

Update: Janssen and Maze Jump on Board Finnish Genomics Project

Update (25/02/2020): Janssen and the US company Maze Therapeutics are the latest pharma companies to sign up as partners in the public-private genomics collaboration FinnGen. FinnGen’s pharma partners now total…

February 25, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 20 Feb 2020

Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies

The German biotech Immatics will partner with GSK and could receive more than €1B from the big pharma for developing cancer immunotherapies based on engineered immune T-cells. Immatics will collaborate…

February 20, 2020 - 3 minutesmins - By Jonathan Smith

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering